Form 4 for SANA Sana Biotechnology, Inc.
Accepted 2023-10-06 00:00:00 ET · period of report 2023-10-05 · accession 0001562180-23-007236 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-06 | 2023-10-05 | SANA | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +6,925 | 5.77M | +0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-05 | A | A | 6,925 | $0.00 | 5,771,965 | D | — | — | (F1) Consists of fully vested restricted stock units for which the Reporting Person has elected to defer settlement until January 1, 2024 pursuant to Sana Biotechnology, Inc.'s Non-Employee Director Compensation Program. |